Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

58.88 +0.55 (+0.94%)
Streaming Delayed Price Updated: 11:33 AM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
4 Analysts Assess Globus Medical: What You Need To Know
 
Via Benzinga
Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
From Globus Medical
Via GlobeNewswire
GLOBUS MEDICAL INC - A (NYSE:GMED) – A Strong Growth Stock with Technical Breakout Potential
Globus Medical (NYSE:GMED) is a strong growth stock with solid fundamentals and a potential technical breakout, making it a candidate for investors seeking growth opportunities in the healthcare... 
Via Chartmill
GLOBUS MEDICAL INC - A (NYSE:GMED) – A Strong Growth Stock with Reasonable Valuation
Globus Medical (NYSE:GMED) offers strong growth, solid profitability, and reasonable valuation, making it an attractive pick for investors seeking affordable growth in the healthcare sector. 
Via Chartmill
Price Over Earnings Overview: Globus Medical
 
Via Benzinga
Is the Market Bullish or Bearish on Globus Medical?
 
Via Benzinga
A Look Into Globus Medical Inc's Price Over Earnings
 
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.  - GMED
From Pomerantz LLP
Via GlobeNewswire
2 Reasons to Watch GMED and 1 to Stay Cautious
Shareholders of Globus Medical would probably like to forget the past six months even happened. The stock dropped 28.9% and now trades at $58.14. This was partly due to its softer quarterly results and... 
Via StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.  - GMED
From Pomerantz LLP
Via GlobeNewswire
1 Cash-Producing Stock with Solid Fundamentals and 2 to Be Wary Of
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Medical Devices & Supplies - Specialty Stocks Q1 Recap: Benchmarking Globus Medical (NYSE:GMED)
Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers. 
Via StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims 0n Behalf of Investors of Globus Medical, Inc. - GMED
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. - GMED
From Pomerantz LLP
Via GlobeNewswire
GMED Q1 Earnings Call: Integration Challenges, New Acquisition, and Market Uncertainties Shape Outlook
Medical device company Globus Medical (NYSE:GMED) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s... 
Via StockStory
Topics Economy
GLOBUS MEDICAL INC - A (NYSE:GMED) – A Strong Growth Stock with Technical Breakout Potential
Globus Medical (NYSE:GMED) shows strong growth fundamentals and a technical setup suggesting a potential breakout. The stock combines revenue growth, profitability, and a favorable chart pattern. 
Via Chartmill
GLOBUS MEDICAL INC - A (NYSE:GMED) - A Strong Growth Stock with Reasonable Valuation
GLOBUS MEDICAL (NYSE:GMED) is a strong growth stock with reasonable valuation, solid profitability, and a healthy balance sheet, making it an attractive option for investors seeking growth at a fair... 
Via Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
From Pomerantz LLP
Via GlobeNewswire
2 Growth Stocks to Add to Your Roster and 1 to Brush Off
Growth is oxygen. But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID... 
Via StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.  - GMED
From Pomerantz LLP
Via GlobeNewswire
This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
 
Via Benzinga
Assessing Globus Medical: Insights From 4 Financial Analysts
 
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.  - GMED
From Pomerantz LLP
Via GlobeNewswire
Globus Medical Announces $500 Million Share Repurchase Program
From Globus Medical
Via GlobeNewswire
GLOBUS MEDICAL INC - A (NYSE:GMED) - A Strong Growth Stock at a Reasonable Price
GLOBUS MEDICAL (NYSE:GMED) offers strong growth potential at a reasonable valuation, backed by solid financial health. A closer look at its fundamentals suggests it could be a compelling pick for... 
Via Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED
From Pomerantz LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.